Support for 'In-Between Visit' Care Management for People with Behavioral Health Diagnoses, Developmental Disabilities and Drug Addiction
Anonymous donor presents $1 million gift to The Ehlers-Danlos Society to jumpstart groundbreaking genomic research into genetic cause of hypermobile Ehlers-Danlos syndrome (hEDS), a rare, degenerative, and all-too-often painful, disabling connective tissue disorder
New service for seniors will be led by Dr. Anna Monias.
Rapidly Growing Patient Populations and New Drug Classes are Key Drivers in this Market According to Greystone Research Associates
Proliferation of Lyophilized Drugs Creating Demand for Patient-Friendly Reconstitution According to Greystone Research Associates
Developers Turning to New Materials and Advanced Electronics According to Greystone Research Associates
Growing Emphasis on Adherence and Adaptive Learning are Key Drivers in this Market According to Greystone Research Associates
Program highlighted in new issue of Better Tennessee magazine
World experts in Portland share the latest Trials and Studies for Cancer at the LDN 2017 Conference.
The Story Behind The (re)brand.
Tailored Therapy Provides Relief to Thousands Living In Texas
Recognizing May as Better Hearing and Speech Month
Leading a 10 Day, 233 Mile Journey by Wheelchair from Yankee Stadium to Washington DC, Determined To Strike Out ALS, May 5-15, 2017
Recognizing April as National Parkinson's Awareness Month
Powerful Cell Guidance Systems' technology is being applied to the treatment of a disease that causes chronic pain for millions of people.
This event is shaping up to overshadow the 2016 event with more prominent speakers added, a larger expo and much higher attendance.